NYSE:TBITrueblue Stock Price, Forecast & News

$15.39

+0.37 (+2.46 %)

(As of 05/26/2020 04:00 PM ET)

Add

Compare

Today's Range

$15.20

Now: $15.39▼

$15.58

50-Day Range

$13.06

MA: $14.47▼

$15.74

52-Week Range

$12.02

Now: $15.39▼

$24.98

Volume319,108 shs

Average Volume448,316 shs

Market Capitalization$556.04 million

P/E RatioN/A

Dividend YieldN/A

Beta1.79

TrueBlue, Inc. provides contingent staffing, recruitment process outsourcing, and contingent staffing management services in the United States, Canada, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The PeopleReady segment offers a range of staffing solutions for blue-collar, contingent on-demand, and skilled labor in construction, manufacturing and logistics, warehousing and distribution, waste and recycling, energy, retail, hospitality, general labor, and other industries under the Labor Ready, CLP Resources, and Spartan Staffing brands. The PeopleManagement segment provides contingent labor and outsourced industrial workforce solutions. It offers recruitment and on-premise management services, and temporary and dedicated drivers for the transportation and distribution industries under Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The PeopleScout segment offers permanent employee recruitment process outsourcing services; and manages customers' contingent labor programs comprising vendor selection, performance management, compliance monitoring, and risk management. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. TrueBlue, Inc. was founded in 1985 and is headquartered in Tacoma, Washington.

Beat the Market (BTM) Rank^™

1.0 Analyst's Opinion

Consensus Rating
Trueblue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $16.00, Trueblue has a potential upside of 4.0% from its current price of $15.39.
Amount of Analyst Coverage
Trueblue has only been the subject of 3 research reports in the past 90 days.

2.4 Community Rank

Outperform Votes
Trueblue has received 304 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Trueblue has received 341 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Trueblue has received 52.87% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Trueblue and other stocks. Vote “Outperform” if you believe TBI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TBI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Trueblue does not currently pay a dividend.
Dividend Growth
Trueblue does not have a long track record of dividend growth.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Trueblue insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.00% of the stock of Trueblue is held by insiders.
Percentage Held by Institutions
97.01% of the stock of Trueblue is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Trueblue are expected to grow by 375.00% in the coming year, from $0.20 to $0.95 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Trueblue is -5.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Trueblue is -5.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Trueblue has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Help supply services

Sub-IndustryHuman Resource & Employment Services

SectorBusiness Services

Current SymbolNYSE:TBI

Previous Symbol

CUSIP89785X10

CIK768899

Webwww.trueblue.com

Phone253-383-9101

Debt

Debt-to-Equity Ratio0.77

Current Ratio3.17

Quick Ratio3.17

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E Ratio76.95

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.37 billion

Price / Sales0.23

Cash Flow$3.10 per share

Price / Cash Flow4.96

Book Value$11.51 per share

Price / Book1.34

Profitability

EPS (Most Recent Fiscal Year)$2.05

Net Income$63.07 million

Net Margins-4.14%

Return on Equity12.19%

Return on Assets6.17%

Miscellaneous

Employees6,200

Outstanding Shares36,130,000

Market Cap$556.04 million

Next Earnings Date8/3/2020 (Estimated)

OptionableOptionable

Receive TBI News and Ratings via Email

Sign-up to receive the latest news and ratings for TBI and its competitors with MarketBeat's FREE daily newsletter.

Trueblue (NYSE:TBI) Frequently Asked Questions

How has Trueblue's stock been impacted by COVID-19 (Coronavirus)?

Trueblue's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TBI stock has increased by 15.3% and is now trading at $15.39. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Trueblue?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Trueblue.

When is Trueblue's next earnings date?

Trueblue is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Trueblue.

How were Trueblue's earnings last quarter?

Trueblue Inc (NYSE:TBI) released its quarterly earnings results on Monday, May, 4th. The business services provider reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.05. The business services provider earned $494.30 million during the quarter, compared to analyst estimates of $495.22 million. Trueblue had a positive return on equity of 12.19% and a negative net margin of 4.14%. The business's revenue was down 10.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.27 earnings per share. View Trueblue's earnings history.

What price target have analysts set for TBI?

3 analysts have issued 12 month price objectives for Trueblue's stock. Their forecasts range from $15.00 to $17.00. On average, they expect Trueblue's stock price to reach $16.00 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View analysts' price targets for Trueblue.

Has Trueblue been receiving favorable news coverage?

News stories about TBI stock have trended positive on Wednesday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trueblue earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave media stories about the business services provider a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near future. View the latest news aboutTrueblue.

Who are some of Trueblue's key competitors?

Some companies that are related to Trueblue include Tradeweb Markets (TW), Robert Half International (RHI), ManpowerGroup (MAN), ASGN (ASGN), Wageworks (WAGE), Insperity (NSP), Korn Ferry (KFY), Kforce (KFRC), Kelly Services (KELYA), Heidrick & Struggles International (HSII), Barrett Business Services (BBSI), GP Strategies (GPX) and Hudson Global (HSON). View all competitors.

What other stocks do shareholders of Trueblue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trueblue investors own include IBM (IBM), Intel (INTC), NVIDIA (NVDA), AT&T (T), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD), Goldman Sachs Group (GS) and USANA Health Sciences (USNA).

Who are Trueblue's key executives?

Trueblue's management team includes the following people:

Mr. A. Patrick Beharelle, CEO & Director (Age 49)
Mr. Derrek L. Gafford, Exec. VP & CFO (Age 48)
Mr. James E. Defebaugh IV, Exec. VP, Gen. Counsel & Sec. (Age 64)
Ms. Taryn R. Owen, Exec. VP (Age 40)
Mr. Sean Ebner, Exec. VP (Age 49)

What is Trueblue's stock symbol?

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Who are Trueblue's major shareholders?

Trueblue's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.34%), ArrowMark Colorado Holdings LLC (6.37%), JPMorgan Chase & Co. (3.92%), State Street Corp (3.65%), Janus Henderson Group PLC (3.25%) and Acadian Asset Management LLC (2.44%). Company insiders that own Trueblue stock include A Patrick Beharelle, Derrek Lane Gafford, James E Defebaugh, Jeffrey B Sakaguchi, Sean A Ebner, Steven C Cooper and Taryn R Owen. View institutional ownership trends for Trueblue.

Which major investors are selling Trueblue stock?

TBI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Martingale Asset Management L P, Seizert Capital Partners LLC, State Board of Administration of Florida Retirement System, Public Sector Pension Investment Board, AQR Capital Management LLC, and SG Americas Securities LLC. Company insiders that have sold Trueblue company stock in the last year include Jeffrey B Sakaguchi, and Taryn R Owen. View insider buying and selling activity for Trueblue.

Which major investors are buying Trueblue stock?

TBI stock was bought by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Invesco Ltd., JPMorgan Chase & Co., Matarin Capital Management LLC, Acadian Asset Management LLC, Deutsche Bank AG, State Street Corp, and Aperio Group LLC. View insider buying and selling activity for Trueblue.

How do I buy shares of Trueblue?

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Trueblue's stock price today?

One share of TBI stock can currently be purchased for approximately $15.39.

How big of a company is Trueblue?

Trueblue has a market capitalization of $556.04 million and generates $2.37 billion in revenue each year. The business services provider earns $63.07 million in net income (profit) each year or $2.05 on an earnings per share basis. Trueblue employs 6,200 workers across the globe.

What is Trueblue's official website?

The official website for Trueblue is www.trueblue.com.

How can I contact Trueblue?

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff